cognitive cybersecurity intelligence

News and Analysis

Bayer Lung Cancer Drug Lands Speedy FDA Nod to Stay Competitive With a Boehringer Ingelheim Med

The accelerated FDA approval of Bayer’s Hyrnuo covers treatment of advanced cases of non-small cell lung cancer with HER2 mutations. It will compete against an HER2-targeting Boehringer Ingelheim pill approved in August.
The post Bayer Lung Cancer Drug Lands Speedy FDA Nod to Stay Competitive With a Boehringer Ingelheim Med appeared first on MedCity News.

Source: medcitynews.com –

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

FOX5 Investigates Scam of the Week: Protecting yourself from pop-ups – fox5vegas.com

FOX5 Investigates Scam of the Week: Protecting yourself from pop-ups fox5vegas.com

New CrystalRAT malware adds RAT, stealer and prankware features – BleepingComputer

New CrystalRAT malware adds RAT, stealer and prankware features BleepingComputer

MedCity FemFwd: ACOG’s New Guidelines Around Endometriosis

In this episode, we’re joined by Dr. Barbara Levy, chief medical officer of Visana Health. We discuss the American College of Obstetricians & Gynecologists’ new

Dallas trio charged with orchestrating ATM malware scheme in East Texas, other areas – cbs19.tv

Dallas trio charged with orchestrating ATM malware scheme in East Texas, other areas cbs19.tv

News and Analysis

Bayer Lung Cancer Drug Lands Speedy FDA Nod to Stay Competitive With a Boehringer Ingelheim Med

Subscribe to newsletter

More Posts

FOX5 Investigates Scam of the Week: Protecting yourself from pop-ups – fox5vegas.com

New CrystalRAT malware adds RAT, stealer and prankware features – BleepingComputer

MedCity FemFwd: ACOG’s New Guidelines Around Endometriosis

Dallas trio charged with orchestrating ATM malware scheme in East Texas, other areas – cbs19.tv

Products

Solutions

Healthcare cybersecurity

Healthcare Threat Intelligence

Use Cases

News and Analysis

Insights

Company